Increased Acute Myocardial Infarction Rates and Cardiovascular Risk Factors among Patients with Human Immunodeficiency Virus Disease
Tóm tắt
Context: Metabolic changes and smoking are common among HIV patients and may confer increased cardiovascular risk.
Objective: The aim of the study was to determine acute myocardial infarction (AMI) rates and cardiovascular risk factors in HIV compared with non-HIV patients in two tertiary care hospitals.
Design, Setting, and Participants: We conducted a health care system-based cohort study using a large data registry with 3,851 HIV and 1,044,589 non-HIV patients. AMI rates were determined among patients receiving longitudinal care between October 1, 1996, and June 30, 2004.
Main Outcome Measures: The primary outcome was myocardial infarction, identified by International Classification of Diseases coding criteria.
Results: AMI was identified in 189 HIV and 26,142 non-HIV patients. AMI rates per 1000 person-years were increased in HIV vs. non-HIV patients [11.13 (95% confidence interval [CI] 9.58–12.68) vs. 6.98 (95% CI 6.89–7.06)]. The HIV cohort had significantly higher proportions of hypertension (21.2 vs. 15.9%), diabetes (11.5 vs. 6.6%), and dyslipidemia (23.3 vs. 17.6%) than the non-HIV cohort (P < 0.0001 for each comparison). The difference in AMI rates between HIV and non-HIV patients was significant, with a relative risk (RR) of 1.75 (95% CI 1.51–2.02; P < 0.0001), adjusting for age, gender, race, hypertension, diabetes, and dyslipidemia. In gender-stratified models, the unadjusted AMI rates per 1000 person-years were higher for HIV patients among women (12.71 vs. 4.88 for HIV compared with non-HIV women), but not among men (10.48 vs. 11.44 for HIV compared with non-HIV men). The RRs (for HIV vs. non-HIV) were 2.98 (95% CI 2.33–3.75; P < 0.0001) for women and 1.40 (95% CI 1.16–1.67; P = 0.0003) for men, adjusting for age, gender, race, hypertension, diabetes, and dyslipidemia. A limitation of this database is that it contains incomplete data on smoking. Smoking could not be included in the overall regression model, and some of the increased risk may be accounted for by differences in smoking rates.
Conclusions: AMI rates and cardiovascular risk factors were increased in HIV compared with non-HIV patients, particularly among women. Cardiac risk modification strategies are important for the long-term care of HIV patients.
Từ khóa
Tài liệu tham khảo
Carr, 1998, A syndrome of peripheral lipodystrophy, hyperlipidaemia and insulin resistance in patients receiving HIV protease inhibitors, AIDS, 12, F51, 10.1097/00002030-199807000-00003
Hadigan, 2003, Prediction of coronary heart disease risk in HIV-infected patients with fat redistribution., Clin Infect Dis, 36, 909, 10.1086/368185
Brown, 2005, Antiretroviral therapy and the prevalence and incidence of diabetes mellitus in the multicenter AIDS cohort study., Arch Intern Med, 165, 1179, 10.1001/archinte.165.10.1179
Stein, 2001, Use of human immunodeficiency virus-1 protease inhibitors is associated with atherogenic lipoprotein changes and endothelial dysfunction., Circulation, 104, 257, 10.1161/01.CIR.104.3.257
Hsue, 2004, Progression of atherosclerosis as assessed by carotid intima-media thickness in patients with HIV infection., Circulation, 109, 1603, 10.1161/01.CIR.0000124480.32233.8A
Carr, 1999, Diagnosis, prediction, and natural course of HIV-1 protease-inhibitor-associated lipodystrophy, hyperlipidaemia, and diabetes mellitus: a cohort study., Lancet, 353, 2093, 10.1016/S0140-6736(98)08468-2
Hadigan, 2001, Metabolic abnormalities and cardiovascular disease risk factors adults with human immunodeficiency virus infection and lipodystrophy., Clin Infect Dis, 32, 130, 10.1086/317541
Periard, 1999, Atherogenic dyslipidemia in HIV-infected individuals treated with protease inhibitors. The Swiss HIV Cohort Study., Circulation, 100, 700, 10.1161/01.CIR.100.7.700
Lichtenstein, 2001, Clinical assessment of HIV-associated lipodystrophy in an ambulatory population., AIDS, 1389
Mary-Krause, 2003, Increased risk of myocardial infarction with duration of protease inhibitor therapy in HIV-infected men., AIDS, 2479
Friis-Moller, 2003, Combination antiretroviral therapy and the risk of myocardial infarction., N Engl J Med, 1993
Currier, 2003, Coronary heart disease in HIV-infected individuals., J Acquir Immune Defic Syndr, 33, 506, 10.1097/00126334-200308010-00012
Klein, 2002, Do protease inhibitors increase the risk for coronary heart disease in patients with HIV-1 infection?, J Acquir Immune Defic Syndr, 30, 471, 10.1097/00126334-200208150-00002
Bozzette, 2003, Cardiovascular and cerebrovascular events in patients treated for human immunodeficiency virus infection., N Engl J Med, 348, 702, 10.1056/NEJMoa022048
Heckbert, 2004, Comparison of self-report, hospital discharge codes, and adjudication of cardiovascular events in the Women’s Health Initiative., Am J Epidemiol, 160, 1152, 10.1093/aje/kwh314
Dolan, 2005, Increased cardiovascular disease risk indices in HIV-infected women., J Acquir Immune Defic Syndr, 39, 44, 10.1097/01.qai.0000159323.59250.83
Liao, 2004, REACH 2010 Surveillance for Health Status in Minority Communities—United States, 2001–2002., MMWR Surveill Summ, 1
Riddler, 2003, Impact of HIV infection and HAART on serum lipids in men., JAMA, 289, 2978, 10.1001/jama.289.22.2978
Grunfeld, 1992, Lipids, lipoproteins, triglyceride clearance, and cytokines in human immunodeficiency virus infection and the acquired immunodeficiency syndrome., J Clin Endocrinol Metab, 74, 1045
Sattler, 2001, Elevated blood pressure in subjects with lipodystrophy., AIDS, 15, 2001, 10.1097/00002030-200110190-00013
U.S. Public Health Service, Office of the Surgeon General, U.S. Office on Smoking and Health, 1990, The health benefits of smoking cessation: a report of the Surgeon General, 1990, Series DHHS publication, no. (CDC) 90–8416. Rockville, MD: U.S. Department of Health and Human Services, Public Health Service, Centers for Disease Control, Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health;, 187
Ross, 1999, Atherosclerosis–an inflammatory disease., N Engl J Med, 340, 115, 10.1056/NEJM199901143400207
Hansson, 2005, Inflammation, atherosclerosis, and coronary artery disease., N Engl J Med, 352, 1685, 10.1056/NEJMra043430
Maggi, 2000, Premature lesions of the carotid vessels in HIV-1-infected patients treated with protease inhibitors, AIDS, 14, F123, 10.1097/00002030-200011100-00001
Shankar, 2005, Indinavir impairs endothelial function in healthy HIV-negative men, Am Heart J, 150, 933, 10.1016/j.ahj.2005.06.005